NovAccess Global Inc. (OTCMKTS:XSNX – Get Rating) was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 7,700 shares, a growth of 97.4% from the October 15th total of 3,900 shares. Based on an average daily volume of 9,100 shares, the days-to-cover ratio is presently 0.8 days.
NovAccess Global Stock Performance
Shares of XSNX opened at $0.20 on Friday. NovAccess Global has a 12 month low of $0.10 and a 12 month high of $0.60. The company's fifty day moving average is $0.18 and its 200-day moving average is $0.21.
Get NovAccess Global alerts:About NovAccess Global
(Get Rating)
NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc was incorporated in 1997 and is headquartered in Chesterland, Ohio.See Also
- Get a free copy of the StockNews.com research report on NovAccess Global (XSNX)
- MarketBeat: Week in Review 11/7 – 11/11
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.